Compare ETFs: IBB vs. LON:XDWH
IBB
LON:XDWH
Comparison
Average Return
In the past year, IBB returned a total of 48.26%, which is significantly higher than LON:XDWH's 17.61% return. Over the past 10 years, IBB has had annualized average returns of 8.74%, compared to 8.83% for LON:XDWH. These numbers are adjusted for stock splits and assume dividends are reinvested.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 8.09% |
| 2 | AMGN | Amgen Inc. | 7.90% |
| 3 | GILD | Gilead Sciences, Inc. | 6.94% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 5.05% |
| 5 | ARGX | argenx SE | 3.73% |
| 6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.15% |
| 7 | NTRA | Natera, Inc. | 2.87% |
| 8 | RVMD | Revolution Medicines, Inc. | 2.74% |
| 9 | BIIB | Biogen Inc. | 2.39% |
| 10 | ILMN | Illumina, Inc. | 2.16% |
| 11 | INSM | Insmed Incorporated | 1.81% |
| 12 | UTHR | United Therapeutics Corporation | 1.80% |
| 13 | ONC | BeOne Medicines AG | 1.77% |
| 14 | MRNA | Moderna, Inc. | 1.75% |
| 15 | INCY | Incyte Corporation | 1.72% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.42% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.31% |
| 18 | ASND | Ascendis Pharma A/S | 1.31% |
| 19 | GMAB | Genmab A/S | 1.10% |
| 20 | EXEL | Exelixis, Inc. | 1.05% |
| 21 | IONS | Ionis Pharmaceuticals, Inc. | 1.03% |
| 22 | MEDP | Medpace Holdings, Inc. | 0.97% |
| 23 | BBIO | BridgeBio Pharma, Inc. | 0.95% |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.90% |
| 25 | TECH | Bio-Techne Corporation | 0.89% |
| View IBB holdings | |||
| LON:XDWH - Xtrackers MSCI World Health Care UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | LLY | Eli Lilly and Company | 11.35% |
| 2 | JNJ | Johnson & Johnson | 6.94% |
| 3 | ABBV | AbbVie Inc. | 4.92% |
| 4 | UNH | UnitedHealth Group Incorporated | 4.40% |
| 5 | SWX: ROP | Roche Holding AG | 3.78% |
| 6 | MRK | Merck & Co., Inc. | 3.77% |
| 7 | LON: AZN | AstraZeneca PLC | 3.69% |
| 8 | SWX: NOVN | Novartis AG | 3.66% |
| 9 | TMO | Thermo Fisher Scientific Inc. | 2.36% |
| 10 | AMGN | Amgen Inc. | 2.32% |
| 11 | GILD | Gilead Sciences, Inc. | 2.13% |
| 12 | ISRG | Intuitive Surgical, Inc. | 1.92% |
| 13 | ABT | Abbott Laboratories | 1.90% |
| 14 | PFE | Pfizer Inc. | 1.90% |
| 15 | CPH: NOVO.B | Novo Nordisk A/S | 1.88% |
| 16 | BMY | Bristol-Myers Squibb Company | 1.49% |
| 17 | DHR | Danaher Corporation | 1.48% |
| 18 | CVS | CVS Health Corporation | 1.48% |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 1.45% |
| 20 | SYK | Stryker Corporation | 1.34% |
| 21 | LON: GSK | GSK plc | 1.32% |
| 22 | EPA: SAN | Sanofi | 1.23% |
| 23 | MDT | Medtronic plc | 1.21% |
| 24 | MCK | McKesson Corporation | 1.17% |
| 25 | ELV | Elevance Health, Inc. | 1.12% |
| View LON:XDWH holdings | |||